Loading...
ST2 as checkpoint target for colorectal cancer immunotherapy
Immune checkpoint blockade immunotherapy delivers promising clinical results in colorectal cancer (CRC). However, only a fraction of cancer patients develop durable responses. The tumor microenvironment (TME) negatively impacts tumor immunity and subsequently clinical outcomes. Therefore, there is a...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253019/ https://ncbi.nlm.nih.gov/pubmed/32376804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.136073 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|